Cytosorb Devices

About

Cytosorb Devices represent an innovative extracorporeal blood purification technology engineered to mitigate the detrimental effects of hyperinflammation in critically ill patients. This advanced medical device functions by adsorbing excessive levels of pro-inflammatory cytokines, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) directly from the patient's blood. By selectively removing these inflammatory mediators, Cytosorb aims to rebalance the immune response, stabilize hemodynamic parameters, and prevent or reverse organ dysfunction often seen in conditions such as sepsis, septic shock, and severe inflammatory response syndrome (SIRS). It is employed as an adjunctive therapy, integrated into existing extracorporeal circuits like hemodialysis or ECMO, and requires operation by highly trained medical personnel within an intensive care unit (ICU) environment, complementing standard medical treatments to improve patient prognosis.

Uses

• Management of sepsis and septic shock
• Treatment of severe inflammatory response syndrome (SIRS)
• Support for organ dysfunction in critical illness
• Reduction of cytokine storm in various conditions

Directions For Use

Used as part of an extracorporeal circuit, typically in an Intensive Care Unit (ICU) setting. Operated by trained medical personnel under strict physician supervision.

Benefits

• Reduces circulating inflammatory mediators
• Helps stabilize hemodynamic parameters
• Supports recovery of organ function
• Potential for improved survival in critical illness
• Adjunctive therapy for complex inflammatory conditions
• Non-pharmacological approach to immune modulation

Side Effects

• Bleeding complications (due to anticoagulation)
• Hypotension or hemodynamic instability
• Electrolyte imbalances (e.g., hypocalcemia)
• Hypothermia
• Access site complications (e.g., infection, hematoma)
• Allergic or hypersensitivity reactions
• Device malfunction
• Anemia
• Thrombocytopenia
• Air embolism (rare)
• Infection risk
• Fluid imbalance

Safety Measures

• Alcohol - Not applicable as Cytosorb Devices are medical devices used in a clinical setting for critically ill patients.
• Pregnancy - Use in pregnant patients in critical care requires careful risk-benefit assessment by the treating physician, considering the severity of the underlying condition.
• Breastfeeding - Not applicable as Cytosorb Devices are medical devices used in a clinical setting for critically ill patients.
• Liver - No direct contraindication, but liver dysfunction may impact overall patient management and coagulation status during treatment.
• Kidney - Can be used safely in patients with kidney conditions, often in conjunction with renal replacement therapy; no direct contraindication.
• Lung - No direct contraindication; can be used to support patients with acute lung injury or ARDS by reducing systemic inflammation.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.